APVO Insider Trading Activity and SEC Form 4 Filings
APVO insider trading summary
Over the past 12 months, insiders at Aptevo Therapeutics Inc. (APVO) reported 1 open-market purchase worth $20K by 1 insider and no sales on SEC Form 4. Net insider buying was $20K.
Latest APVO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 10, 2025 | Grady Grant III | Insider | Buy | $20K (13,513 @ $1.49) |
| Nov 23, 2021 | Kevin C Tang | Insider | Sell | $886K (75,491 @ $11.74) |
| Nov 23, 2021 | Tang Capital Management LLC | Insider | Sell | $2.2M (161,336 @ $13.52) |
| Nov 23, 2021 | Kevin C Tang | Insider | Sell | $2.2M (161,336 @ $13.52) |
| Nov 23, 2021 | Tang Capital Management LLC | Insider | Sell | $1.6M (124,509 @ $12.45) |
| Nov 23, 2021 | Tang Capital Partners LP | Insider | Sell | $2.2M (161,336 @ $13.52) |
| Nov 23, 2021 | Tang Capital Management LLC | Insider | Sell | $886K (75,491 @ $11.74) |
| Nov 23, 2021 | Kevin C Tang | Insider | Sell | $1.6M (124,509 @ $12.45) |
| Nov 23, 2021 | Tang Capital Partners LP | Insider | Sell | $1.6M (124,509 @ $12.45) |
| Nov 23, 2021 | Tang Capital Partners LP | Insider | Sell | $886K (75,491 @ $11.74) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.